Get startedLog in
    Picture of ExpreS2ion Biotech Holding AB logo

    EXPRS2 — ExpreS2ion Biotech Holding AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: ExpreS2ion Announces Further Preclinical Proof-Of-Concept Results For HER2-cVLP Breast Cancer Vaccine

    Picture of ExpreS2ion Biotech Holding AB logoExpreS2ion Biotech Holding AB
    04/01/2022 07:32
    Jan 4 (Reuters) - ExpreS2ion Biotech Holding AB  EXPRS2.ST :
    * ANNOUNCES FURTHER POSITIVE PRECLINICAL PROOF-OF-CONCEPT RESULTS FOR THE HER2-CVLP BREAST
CANCER
VACCINE
    * ES2B-C001 DEMONSTRATED PROOF-OF-CONCEPT ALSO IN HER2-TRANSGENIC PREVENTIVE AS WELL AS
THERAPEUTIC TUMOR MICE MODELS

Source text for Eikon:  ID:nWkrcgx9xN 
Further company coverage:  EXPRS2.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on ExpreS2ion Biotech Holding AB

    See all news